News

Ideas That Generate Results

Antibody Drug Conjugates have revolutionized the field of cancer over the past decades. Unlike traditional cancer therapies which damaged healthy tissues, ADCs utilize the monoclonal antibodies to bind specifically to the target antigen and deliver highly potent cytotoxic agents. This synergistic combination has given rise to a highly specific and effective class of cancer drugs.
 
According to the RNCOS report entitled “Global Antibody Drug Conjugates Drug Sales, Pipeline Analysis (By Phase, Linker, Technology, and Indication) & Global Market Forecasts to 2023”, the Global Antibody Drug Conjugate Market is anticipated to witness a double digit growth during 2017-2023. The report provides information about the current and future market scenario of the Global ADCs Market. The report also highlights the major drivers, such as increasing incidences of cancer and advances in linking technologies, for the Global Antibody Drug Conjugates Market. Furthermore, the report also gives information related to the commercially available ADCs such as ADCETRIS, Kadcyla, Mylotarg and Besponsa.
 
Moreover, few hindrances, such as high cost of production cost, lack of experienced manufacturers and regulatory challenges, which are slowing down the growth of the Global ADCs Market, have also been mentioned in the report. In addition, the report also highlights various trends and developments taking place in this market.
 
Furthermore, in this report, we have structured the information regarding ADCs at various stages of clinical development that are under research or in collaboration, and those individually being developed by companies. The pipeline chapter provides in depth analysis of ADCs of companies as well as research organizations by clinical phase, indications, type of linker, drugs, and technology. Additionally, the study provides all-inclusive current analysis of various ADCs in advanced as well as early stages of development. Moreover, our report places an emphasis on the strategic alliances that can impact industry’s growth.
 
The prominent players in Global Antibody Drug Conjugates market have been discussed in the last section of the report. A brief business overview and financial information about each of these players has been provided, along with their product portfolios, product pipeline and recent developments. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Global Antibody Drug Conjugates Market.
 
Some of the key findings of the report are:
 
•        Antibody Drug Conjugates at the Forefront of Treating Hematological Malignancies
 
For FREE SAMPLE of this report visit: http://rncos.viewpage.co/Global-Antibody-Drug-Conjugates-Drug-Sales-Market-Forcast-2023
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm